Takeda UK and Ireland

Integrity and respect for our patients are at the heart of our universal value system, guiding us in all that we do. 🤝🌍 Our passion and relentless pursuit of life-transforming treatments for patients are deeply rooted in our history, which dates back to 1781 in Japan. Over the past 242 years, we have continuously evolved, innovated, and expanded our capabilities to meet the ever-changing needs of patients around the world. Our legacy is not just about the past; it is about the future we are building. We are committed to pushing the boundaries of what is possible in medicine, driven by the belief that every patient deserves the best care. Learn more about our values and history 👇

Today, we celebrate 76 years of the NHS. At Takeda, we value our partners and are proud to work across the NHS, alongside many other organisations, to provide the care that patients need. We extend our gratitude to the dedicated NHS staff—nurses, doctors, administrative professionals, and all others—who work tirelessly to support our health. We are so grateful for all you do! #TakedaUK

🌈 What a fantastic day at the Dublin Pride Parade with our incredible team! Despite the rain, we had an amazing time singing and dancing our way through the capital. A huge thank you to our amazing Take Pride employee resource group for organising. #DublinPride ##WeAreTakedaUKandIreland 🏳️🌈 

Yesterday, we were delighted to visit Imperial College London's White City Campus with our Paddington Life Sciences Partners. It was a great afternoon to learn more about the great work that White City Innovation District does. We look forward to further opportunities in this collaborative partnership to unite sectors and grow and innovate together! 🙌

According to The European Federation of Pharmaceutical Industries and Associations (EFPIA)’s 2021 report, England and Scotland are jointly ranked 13th in Europe in terms of access to combination treatments. Slipping down 10 places!   If a comprehensive solution isn’t found, the UK clinical community will continue to face frustration if treatments, known to be beneficial in clinical trials, cannot be used routinely in the NHS. There is the risk that treatment standards could fall behind that of other countries.     As part of our video series, 'Combination Treatments: Why Access is Needed’, Helen M Taylor (Programme Access Lead at Takeda UK&I), Eric Low (Member of Takeda’s Advisory Group), and Vanessa Ohlmeyer (Head of Medical Affairs, Oncology at Takeda UK&I) discuss the implications for the life sciences industry and patients, as well as our proposed solution to tackle the access barriers.   For further information on our proposed solution visit here: https://lnkd.in/eY9c4UbD   #CombinationTreatments  

Our teams in the UK and Ireland had a blast celebrating Founders Day! 🎉 At our UK & Ireland Annual Conference, Shane Ryan and Mikito Ishida shared our history and hosted a fun bonsai tree workshop, making it a day to remember.   In Bray, we enjoyed a Japanese-themed lunch, rolling demos, origami workshops, and a quiz about Takeda's fascinating history. The day then continued with a townhall where we dived into our heritage and applauded our colleagues' contributions.  The highlight? Announcing the Bray People Recognition Awards 2024 winners! 🏆 Meanwhile, over at the Grange Castle site, we marked Takeda's 243rd Anniversary with a BBQ! Think quizzes, spot prizes, and socialising over burgers and ice-cream – a great way to celebrate! Huge thanks to everyone who made these days so incredibly special! Check out some highlights below. 📸 🌿 #FoundersDayFun #TeamSpirit #WeAreTakedaUKandIreland

After a long period of collaboration to address the complex challenges faced by combination treatments, we are encouraged by the publication of the prioritisation statement from the Competition and Markets Authority.   This statement will allow progression towards finding a solution that supports patient access to combination treatments and we are pleased that Takeda was able to inform the work of the ABPI and the CMA to bring it to fruition.   Takeda will continue to work on addressing the access challenges faced by combination treatments - watch the video below to hear from Emma Roffe (Oncology Country Head, Takeda UK & Ireland) and Jane Lyons (CEO, Cancer52) on why they are so important to patients and their outcomes.   For further information on Takeda’s work in this area visit here: https://lnkd.in/eY9c4UbD   #CombinationTreatments  #Cancer52

June is Pride Month! 🌈 This year’s theme “Better Together: Pride in Unity” emphasizes the importance of solidarity and togetherness within the LGBTQ community and allies.   At Takeda, we truly believe that different identities, experiences, generations and perspectives contribute to a more vibrant and resilient community. We take a values-based approach to inclusive patient experiences, inclusive work environments, workforce diversity and sustainable societal impact.   This month, we look forward to celebrating Pride with various activities including a panel/networking event run by the Proud Science Alliance and our participation in the Dublin Pride Parade. Stay tuned for more!   #TakedaUKandIreland

Did you know dengue is the fastest-spreading mosquito-borne virus in the world?[i].   This World Dengue Day we want to raise awareness of this disease which affects millions of people worldwide each year [ii].   Last year we launched ‘Explore Uninterrupted’ – a disease awareness campaign initiated and funded by Takeda to educate holidaymakers in the UK and Ireland on dengue fever and the importance of mosquito bite prevention.   Watch the video below to learn about Ken’s experience with Dengue 👇   You can also learn more here: https://lnkd.in/eiE3dt7J   [i] Colón-González F et al. ‘Projecting the risk of mosquito-borne diseases in a warmer and more populated world: a multi-model, multi-scenario intercomparison modelling study’ Lancet Planet Health 2021 [ii]  World Health Organisation (WHO). Dengue and Severe Dengue. Available at: https://lnkd.in/fhV58XH (Accessed June 2024). World Health Organization (WHO) The United Nations agency working to promote health, keep the world safe and serve the vulnerable. C-ANPROM/GB/CORP/0297 June 2024

Today we celebrate Takeda's 243rd anniversary. Takeda’s anniversary is a reminder that our history is an important part of who we are, and we will continue to uphold Takeda’s legacy of being a values-based, resilient and future-ready organisation. We honour our principles every June 12th– also known as Founder’s Day – by celebrating our strong foundation, rich history and commitment to delivering our vision of providing life-transforming treatments to more patients worldwide.   As part of our celebrations our team will gather to reflect on our heritage and look ahead to the future! Stay tuned as we’ll be sharing more later this month.   #TakedaUKandIreland